Log in
Enquire now
‌

US Patent 11180512 Boronic acid derivatives and therapeutic uses thereof

Patent 11180512 was granted and assigned to Qpex Biopharma on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Qpex Biopharma
Qpex Biopharma
0
Current Assignee
Qpex Biopharma
Qpex Biopharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111805120
Patent Inventor Names
Scott J. Hecker0
Olga Rodny0
Raja K. Reddy0
Tomasz Glinka0
Date of Patent
November 23, 2021
0
Patent Application Number
167939650
Date Filed
February 18, 2020
0
Patent Citations Received
‌
US Patent 12016868 Boronic acid derivatives and therapeutic uses thereof
0
‌
US Patent 11999759 Boronic acid derivatives and therapeutic uses thereof
0
Patent Primary Examiner
‌
Bruck Kifle
0
Patent abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11180512 Boronic acid derivatives and therapeutic uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.